AUTHOREA
Log in
Sign Up
Browse Preprints
LOG IN
SIGN UP
Essential Maintenance
: All Authorea-powered sites will be offline 4pm-6pm EDT Tuesday 28 May for essential maintenance.
We apologise for any inconvenience.
Supat Chamnanchanunt
Public Documents
1
Tocilizumab for treating severe COVID-19 pneumonia refractory to combined hydroxychlo...
Manoon Surabotsophon
and 11 more
July 20, 2020
Three patients with COVID-19 pneumonia received treatment with hydroxychloroquine combined with lopinavir plus ritonavir and favipiravir. Two patients early diagnosed with COVID-19 pneumonia received tocilizumab at severe pneumonia diagnosed and survived. The third patient was late diagnosed and received tocilizumab when the disease progressed to ARDS, and passed away.